Concepedia

Carl J. Baldick

CJ

22

Publications

3K

Citations

19

H-Index

1987

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

National Institute of Allergy and Infectious Diseases

Bristol-Myers Squibb (Germany)

National Institutes of Health

Princeton University

Carl J. Baldick is an author at Bristol-Myers Squibb (United States) specializing in medicine, virology, and immunology.

Top concepts

Publications per year

1987–2012

22

Publications

22

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy #

Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick et al. · Hepatology · 2009 · 810 citations · Full text

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

Richard J. Colonno, Ronald E. Rose, Carl J. Baldick et al. · Hepatology · 2006 · 347 citations · Full text

, , +15

Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions Present

Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick et al. · Antimicrobial Agents and Chemotherapy · 2006 · 239 citations · Full text

Sequence specificity of mRNA N6-adenosine methyltransferase

Tünde Csépány, Amy Lin, Carl J. Baldick et al. · Journal of Biological Chemistry · 1990 · 187 citations · Full text

, , +11

Inhibition of Hepatitis B Virus Polymerase by Entecavir

David R. Langley, Ann W. Walsh, Carl J. Baldick et al. · Journal of Virology · 2007 · 187 citations · Full text

, , +15

Rows per page

1–5 of 22